-
Je něco špatně v tomto záznamu ?
Multiple thrombophilia mutations as a possible cause of premature myocardial infarction
G. Dostálová, J. Bělohlávek, Z. Hlubocká, K. Bayerová, P. Bobčiková, T. Kvasnička, J. Kvasnička, A. Linhart, D. Karetová,
Jazyk angličtina Země Rakousko
Typ dokumentu kazuistiky, časopisecké články
- MeSH
- antigeny genetika MeSH
- ateroskleróza genetika MeSH
- faktor V genetika MeSH
- genetická predispozice k nemoci genetika MeSH
- glykoproteiny membrány trombocytů genetika MeSH
- infarkt myokardu genetika MeSH
- inhibitor aktivátoru plazminogenu 1 genetika MeSH
- lidé středního věku MeSH
- lidé MeSH
- methylentetrahydrofolátreduktasa (NADPH2) genetika MeSH
- mutační analýza DNA * MeSH
- polymorfismus genetický genetika MeSH
- protrombin genetika MeSH
- rizikové faktory MeSH
- trombofilie genetika MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
The incidence of acute myocardial infarction (AMI) increases with clustering of predisposing risk factors. In younger subjects with a positive family history of AMI occurring in relatives under the age of 60 years without obvious risk factors for atherosclerosis, there is a potential for strong inherited traits contributing to the risk of coronary disease. Among them there is increasing evidence that hereditary thrombophilia may play a major role. We present a unique case of a patient developing AMI at the age of 48 years. In this patient, without traditional risk factors for atherosclerosis, eight mutations and polymorphisms in six different genes were identified: polymorphism of factor V Leiden (1691 GA), factor II prothrombin (20210 GA), methylenetetrahydrofolate reductase (MTHFR, 677 CT and 1298 AC), plasminogen activator inhibitor 1 (PAI-1) polymorphism 4G/5G and glycoprotein VI (GP6, 13254 TC, Ser219Pro). All could be involved in the pathogenesis of the arterial thrombosis. Although such associations are extremely rare, it underlines the importance of thrombophilia assessment in cases with otherwise unexpected coronary disease occurring at young age. According to our experience, in the case of documented hereditary thrombophilia lineal relatives should be examined and/or followed up.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033949
- 003
- CZ-PrNML
- 005
- 20181012111328.0
- 007
- ta
- 008
- 181008s2017 au f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00508-017-1193-z $2 doi
- 035 __
- $a (PubMed)28382527
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a au
- 100 1_
- $a Dostálová, Gabriela $u Second Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 12808, Prague, Czech Republic. gabriela.dostalova@vfn.cz.
- 245 10
- $a Multiple thrombophilia mutations as a possible cause of premature myocardial infarction / $c G. Dostálová, J. Bělohlávek, Z. Hlubocká, K. Bayerová, P. Bobčiková, T. Kvasnička, J. Kvasnička, A. Linhart, D. Karetová,
- 520 9_
- $a The incidence of acute myocardial infarction (AMI) increases with clustering of predisposing risk factors. In younger subjects with a positive family history of AMI occurring in relatives under the age of 60 years without obvious risk factors for atherosclerosis, there is a potential for strong inherited traits contributing to the risk of coronary disease. Among them there is increasing evidence that hereditary thrombophilia may play a major role. We present a unique case of a patient developing AMI at the age of 48 years. In this patient, without traditional risk factors for atherosclerosis, eight mutations and polymorphisms in six different genes were identified: polymorphism of factor V Leiden (1691 GA), factor II prothrombin (20210 GA), methylenetetrahydrofolate reductase (MTHFR, 677 CT and 1298 AC), plasminogen activator inhibitor 1 (PAI-1) polymorphism 4G/5G and glycoprotein VI (GP6, 13254 TC, Ser219Pro). All could be involved in the pathogenesis of the arterial thrombosis. Although such associations are extremely rare, it underlines the importance of thrombophilia assessment in cases with otherwise unexpected coronary disease occurring at young age. According to our experience, in the case of documented hereditary thrombophilia lineal relatives should be examined and/or followed up.
- 650 _2
- $a antigeny $x genetika $7 D000941
- 650 _2
- $a ateroskleróza $x genetika $7 D050197
- 650 12
- $a mutační analýza DNA $7 D004252
- 650 _2
- $a faktor V $x genetika $7 D005165
- 650 _2
- $a genetická predispozice k nemoci $x genetika $7 D020022
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a methylentetrahydrofolátreduktasa (NADPH2) $x genetika $7 D042965
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a infarkt myokardu $x genetika $7 D009203
- 650 _2
- $a inhibitor aktivátoru plazminogenu 1 $x genetika $7 D017395
- 650 _2
- $a glykoproteiny membrány trombocytů $x genetika $7 D010980
- 650 _2
- $a polymorfismus genetický $x genetika $7 D011110
- 650 _2
- $a protrombin $x genetika $7 D011516
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a trombofilie $x genetika $7 D019851
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bělohlávek, Jan $u Second Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 12808, Prague, Czech Republic.
- 700 1_
- $a Hlubocká, Zuzana $u Second Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 12808, Prague, Czech Republic.
- 700 1_
- $a Bayerová, Kristýna $u Second Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 12808, Prague, Czech Republic.
- 700 1_
- $a Bobčiková, Petra $u Institute of Medical Biochemistry and Laboratory Diagnostics, the Thrombosis Center, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Kvasnička, Tomáš $u Institute of Medical Biochemistry and Laboratory Diagnostics, the Thrombosis Center, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Kvasnička, Jan $u Institute of Medical Biochemistry and Laboratory Diagnostics, the Thrombosis Center, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Linhart, Aleš $u Second Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 12808, Prague, Czech Republic.
- 700 1_
- $a Karetová, Debora $u Second Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague, U Nemocnice 2, 12808, Prague, Czech Republic.
- 773 0_
- $w MED00010762 $t Wiener klinische Wochenschrift $x 1613-7671 $g Roč. 129, č. 13-14 (2017), s. 503-508
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28382527 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181012111820 $b ABA008
- 999 __
- $a ok $b bmc $g 1340361 $s 1030943
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 129 $c 13-14 $d 503-508 $e 20170405 $i 1613-7671 $m Wiener klinische Wochenschrift $n Wien Klin Wochenschr $x MED00010762
- LZP __
- $a Pubmed-20181008